FMP
Nemaura Medical Inc.
NMRD
NASDAQ
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
0.06 USD
-0.012 (-20%)
About
ceo
Dr. Dewan Fazlul Hoque Chowdhury Ph.D.
sector
Healthcare
industry
Medical - Devices
website
https://nemauramedical.com
exchange
NASDAQ
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
CIK
0001602078
ISIN
US6404422080
CUSIP
640442208
Address
57 West 57th Street
Phone
646 416 7912
Country
US
Employee
36
IPO Date
Feb 5, 2018
Key Executives
